Are psychedelics an antidote to pessimism?
Research indicates that psychedelic therapy can improve mental health outcomes by addressing the pessimism bias.
Read morePSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Are psychedelics an antidote to pessimism?
Research indicates that psychedelic therapy can improve mental health outcomes by addressing the pessimism bias.
Read moreThe connection between the psychedelic movement and Indigenous medicine is complex and multifaceted.
Indigenous-led Medicine conservation is biocultural conservation.
It is NOT an effort to simply preserve these medicines (and supply chains) – or their constituent molecules and/or specific habitat – but the entire ecological, social and cultural milieus within which they exist, and from which they cannot be separated without compromising the system as a whole.
Read moreMDMA therapy for PTSD could become a new treatment option for millions of people living with trauma. The clinical evidence is growing.
Read moreHere’s a look at Arctic shamanism, and journeying into psychedelic realms.
Read moreDifferent psychedelics show unique promise for treating mental illness, from PTSD to depression and anxiety. This article compares MDMA and LSD.
Read moreA new study shows that the psychedelic drug ibogaine shows preliminary promise for traumatic brain injury.
Read moreHere’s a great write up on historian Benjamin Breen’s new book, “Tripping on Utopia: Margaret Mead, the Cold War and the Troubled Birth of Psychedelic Science”.
Read moreAt a forest facility in Oregon, the first US state to allow supervised use of the drug, students work toward becoming licensed trip facilitators.
Read moreA lot can come into play here, including set and setting, dosage, purity and quality of the psychedelic, and integration and intentions.
That, in turn, can lead to serious or even fatal heart issues like arrhythmias or valvular heart disease.
So far, there’s been little research on the link between repeated psychedelics use and heart health, but this week, researchers at the University of Fribourg Center for Psychiatric Research in Switzerland published a paper in the Journal of Psychopharmacology reviewing the existing evidence.
“It is possible that chronic microdosing may carry a risk of fibrosis and valvular heart disease, which should be assessed in future studies,” the authors write.
“Any future work considering longer microdosing regimens should incorporate breaks and regular screening for vascular abnormalities.”
Keep reading for eight frequently asked questions about ayahuasca globalization.
Read more